Early research (Phase 1)Ended earlyNCT02008851What this trial is testingA Phase 1, Open-label Safety Study of NKA in Patients With Type 2 DiabetesWho this might be right forChronic Kidney Disease Tengion 1
Testing effectiveness (Phase 2)Study completedNCT05018416What this trial is testingRenal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)Who this might be right forChronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus Prokidney 53
Testing effectiveness (Phase 2)Study completedNCT01807221What this trial is testingPhase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease AloneWho this might be right forHeart Failure Bayer 1,066
Post-approval studies (Phase 4)Looking for participantsNCT07026539What this trial is testingEffect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.Who this might be right forType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases University of Aarhus 80
Not applicableActive Not RecruitingNCT07541729What this trial is testingEffect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes (T2DM)Who this might be right forType 2 Diabetes Mellitus (T2DM)Oxidative StressInflammation Chronic Universidad Autonoma de Zacatecas 40
Large-scale testing (Phase 3)Study completedNCT01986855What this trial is testingThe Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 468
Not applicableStudy completedNCT05465317What this trial is testingEvaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney DiseaseWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 62,197
Not applicableStudy completedNCT03157960What this trial is testingEffect of Acute Fructose Load in HumanWho this might be right forChronic Kidney DiseasesDiabetes Mellitus, Type 2 Karolinska University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02358096What this trial is testingEvaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forChronic Kidney DiseaseType 2 Diabetes Astellas Pharma Europe B.V. 125
Not applicableStudy completedNCT03921242What this trial is testingComparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney DiseaseWho this might be right forDiabetes Mellitus, Type 2Renal Insufficiency, Chronic Weill Medical College of Cornell University 4,888
Not applicableStudy completedNCT04190251What this trial is testingPANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support ProgramWho this might be right forDiabetes Mellitus, Type 2Renal Insufficiency, Chronic Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 73
Testing effectiveness (Phase 2)Study completedNCT05254002What this trial is testingLearn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 DiabetesWho this might be right forType 2 Diabetes MellitusChronic Kidney Disease Bayer 1,664
Not applicableStudy completedNCT02864914What this trial is testingPost-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 InhibitorsWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 333,580
Not applicableStudy completedNCT04006028What this trial is testingKidney Biopsy Indications in Type 2 Diabetes PatientsWho this might be right forType 2 Diabetes, Chronic Kidney Disease Rennes University Hospital 500
Large-scale testing (Phase 3)Study completedNCT05998837What this trial is testingGLUcose Transport and REnalPROtection in Chronic Kidney DiseaseWho this might be right forChronic Kidney DiseaseDiabetes Mellitus, Type 2Hypertension IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 34
Testing effectiveness (Phase 2)Study completedNCT02218099What this trial is testingEvaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseWho this might be right forHealthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT06820567What this trial is testingEffects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKDWho this might be right forChronic Kidney DiseasesDiabetes Type 2 Assiut University 210
Large-scale testing (Phase 3)Study completedNCT00141453What this trial is testingORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialWho this might be right forDiabetic NephropathyType 2 Diabetes MellitusProteinuria Daiichi Sankyo Co., Ltd. 577
Testing effectiveness (Phase 2)Study completedNCT01955694What this trial is testingPhase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease AloneWho this might be right forHeart Failure Bayer 72
Not applicableStudy completedNCT06659718What this trial is testingEmulation of the SOUL Diabetes Trial in Healthcare ClaimsWho this might be right forDiabetes Mellitus, Type 2 Brigham and Women's Hospital 43,650